Oncology and Pathology, MV
1 – 10 of 2065
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
- 2018
- The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
- Being acknowledged by others and bracketing negative thoughts and feelings : Frail older people’s narrations of how existential loneliness is eased
- FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
- Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
- Multidimensional transcriptomics provides detailed information about immune cell distribution an identity in HER2+ breast tumors
- The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
- Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
- Benefits, barriers and opinions on multidisciplinary team meetings : A survey in Swedish cancer care